All Medicare Advantage Enrollees Should Do This By March 31

Medicare Advantage enrollees have a special open enrollment window from Jan. 1 through Mar. 31 during which they may make a single change: switch to a different Medicare Advantage plan or abandon Medicare Advantage for original Medicare. The period is a key opportunity for retirees to reduce unexpected costs or improve provider access if their current plan is too costly, limits networks, imposes prior authorization delays, or restricts supplemental benefits; otherwise they remain locked into their plan for the remainder of the year.

Analysis

Market structure: Medicare Advantage's Jan 1–Mar 31 special enrollment window amplifies short-term churn risk across managed-care incumbents (UNH, HUM, ELV) and creates a predictable seasonal demand shock for plan marketing and underwriting. Winners are scale players with broad networks and star-rating leverage (UNH, HUM); losers are niche/regional MA specialists (CNC, MOH) and out-of-network-heavy hospitals where network narrowing reduces admissions. Pricing power shifts toward plans that can tighten networks and prior-auth controls; incremental enrollee mix swing of 1–3% could move EPS ~2–5% for large insurers over the next 12 months.

Risk assessment: Tail risks include CMS reimbursement cuts, star-rating downgrades, or successful prior-auth litigation that could raise medical loss ratios by 200–500bp; these are low probability but high impact over 6–24 months. Immediate risk window is now–Mar 31 (enrollment flows), short-term is Apr–Jun (claims realization and CMS data), long-term is policy cycles (annual CMS rulemaking). Hidden dependencies: star-rating bonus mechanics, regional provider contracting capacity, and PBM formulary changes that shift drug spend between Medicare Part D and MA.

Trade implications: Core directional trade: modest overweight large diversified MA (UNH 2–3% position, HUM 1–2%) entered before Mar 31 to capture enrollment gains; pair trade: long UNH vs short Centene (CNC) 1–2% to express scale/underwriting advantage. Options: buy UNH May 2026 5% OTM call spread sized to 1% portfolio risk to limit capital; buy short-dated put protection on hospital operators (HCA 3–6 month puts) if exposure >3%. Rotate modestly into managed-care and away from hospital/IDN equities over the next 3–6 months.

Contrarian angles: Consensus underestimates regulatory cliff risk — markets may be underpricing a 200–500bp MLR increase from litigation or CMS rule changes, which would compress margins for CNC/MOH beyond enrollment losses. Historical parallel: early ACA exchange enrollment churn where scale protected margins; here scale + PBM control matters more. Unintended consequence: aggressive network narrowing could provoke political/regulatory backlash, reversing pricing power within 12–24 months.

Key Decisions for Investors

• Establish a 2–3% long position in UnitedHealth (UNH) before Mar 31 to capture likely net-new MA enrollment and star-rating tailwinds; plan to trim to 1–1.5% by Jun if CMS enrollment data (April report) shows <0.5% net gain vs baseline.
• Add a 1–2% short position in Centene (CNC) as a relative-value play vs UNH — CNC is more exposed to state rate pressure and smaller scale; reduce or cover within 3 months if CNC outperforms UNH by >5% intraperiod.
• Buy a UNH May 2026 call spread (approx. 5%/12% OTM) sized to 1% portfolio risk to capture upside while capping premium outlay; exit or roll on May expiration or if UNH moves +8% before April payroll-cycle enrollment print.
• Reduce direct exposure to hospital/operators (e.g., HCA) by 2–4% and purchase 3–6 month protective puts on remaining position if MA network narrowing announcements increase (trigger: two or more major insurers announce material network cuts in a single state).